“Antitumor effects of iridomyrmecin in HeLa cervical cancer cells are mediated via apoptosis induction, loss of mitochondrial membrane potential, cell cycle arrest and down-regulation of PI3K/Akt and up-regulation of lncRNA CCAT2 expression”, Bangladesh J Pharmacol, vol. 11, no. 4, pp. 856–862, Oct. 2016, doi: 10.3329/bjp.v11i4.27539.